Please login to the form below
inflammatory diseases
This page shows the latest inflammatory diseases news and features for those working in and with pharma, biotech and healthcare.
Pfizer and Gero collaborate on fibrotic disease research
In December 2022, Pfizer launched a new company with Roivant Sciences to develop RVT-3101 for inflammatory and fibrotic diseases. ... The new company, which has been created to develop these programmes, will be fully responsible for funding global
Latest news
-
Gilead and EVOQ Therapeutics partner in deal potentially worth over $650m
Flavius Martin, executive vice president, research at Gilead, said: “Despite key advances over the past two decades, there remains significant unmet need for people living with inflammatory and autoimmune diseases. ... There are more than 100 chronic
-
Sanofi and Regeneron’s Dupixent granted EC approval for prurigo nodularis
inflammatory skin diseases due to the extreme itch it causes. ... 2 inflammation that plays a major role in multiple related and often co-morbid diseases.
-
Takeda to acquire Nimbus’ TYK2 inhibitor in deal worth $6bn
Takeda has announced it will acquire Nimbus Therapeutics' NDI-034858, an oral, selective allosteric tyrosine kinase 2 (TYK2) inhibitor being evaluated for the treatment of multiple autoimmune diseases, in a deal ... the differentiation of this molecule
-
Amgen announces plans to acquire Horizon for $27.8bn in biggest pharma deal for 2022
criteria’. Amgen will benefit from gaining several approved therapies as part of the deal, with Horizon’s pipeline of rare autoimmune and inflammatory disease drugs bolstering Amgen’s offering. ... strategy of delivering long-term growth by
-
Pfizer and Roivant form new company to develop inflammatory disease drug
Pfizer and Roivant Sciences have launched a new company focused on developing RVT-3101, a fully human monoclonal antibody targeting TL1A, for inflammatory and fibrotic diseases. ... Inflammatory bowel diseases, including UC and Crohn’s disease, affect
More from news
Approximately 7 fully matching, plus 166 partially matching documents found.
Latest Intelligence
-
The importance of value when treating patients
Similarly, at the Netherlands Heart Registry, a non-profit organisation facilitating a VBHC programme for cardiac diseases from 2015- 2017, the 120-day mortality for combined aortic valve disease and coronary ... Immune-mediated inflammatory diseases
-
Switzerland: a life sciences hub
oral treatments to treat patients with inflammatory bowel diseases. ... The company has been using artificial intelligence for the past eight years to help detect certain diseases such as cancer.
-
20 for 2020 – Five pharma leaders to watch in 2020
In the meantime, Sanofi is stepping up its focus in other areas like immunological and inflammatory diseases, rare blood disorders and vaccines, as well as cancer – an area it had been ... Meanwhile, Galapagos looks set to continue adding to its
-
Innovation in merger control and the impact on the pharmaceutical sector
Specifically, Hospira was selling Inflectra, an infliximab biosimilar used to treat several chronic inflammatory diseases, notably the inflammation of Crohn’s disease, while Pfizer was in an advanced stage of developing
-
‘How is your day?’
Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have. ... These are: Primary Immunodeficiency Diseases (PID – causes severe infections); Chronic Inflammatory Demyelinating Polyneuropathy (CIDP
More from intelligence
Approximately 0 fully matching, plus 14 partially matching documents found.
Latest appointments
-
Dr Kunwar Shailubhai appointed CEO of Tiziana Life Sciences
He has 30 years’ experience in research and development specifically in gastrointestinal disorders, inflammatory diseases and cancers, and previously co-founded Synergy Pharmaceuticals and served as its chief scientific officer.
-
Kymab appoints its first chief medical officer
She has over 20 years of experience biomedical research and has focused on pathogenic mechanisms, underlying chronic inflammatory diseases and the interface between autoimmunity and cancer.
-
Dr Li Zhou joins TxCell as cell engineering VP
Dr Zhou will lead the team's discovery and engineering activities on Chimeric Antigen Receptor in Treg cells ( CAR-Treg) for immunotherapy of severe chronic autoimmune and inflammatory diseases and organ
-
Vedanta Biosciences appoints two new heads
Vedanta is advancing a pipeline of product candidates designed to treat autoimmune, inflammatory and infectious diseases using technology that mines the human microbiome for potent pharmaceutical products.
-
Lorin Johnson joins Atlantic Healthcare board
Atlantic's lead asset, alicaforsen for the treatment of the inflammatory bowel diseases ulcerative colitis and pouchitis.
More from appointments
Approximately 0 fully matching, plus 12 partially matching documents found.
Latest from PMHub
-
Shaping the dermatology landscape: Independent expert analysis of the pipeline in 5 disease areas
FIDE joins other Expert Partnerships at FH including IHEP, which specializes in diseases of the liver and i-ONE, which specializes in oncology and hematology. ... We sat down with members of the FIDE Steering Committee to explore the latest key
-
Fishawack Health welcomes expert-led dermatology initiative FIDE to its group
Fishawack Health welcomes FIDE, an independent organization providing its clients with insight from clinical key opinion leaders in inflammatory dermatology. ... About FIDE. FIDE is a full-service consultancy with extensive expertise in the
-
A magic milestone: Sally’s 10-year #LucidLife workiversary
room, to the impact you’ve made on people’s lives with inflammatory diseases.
-
Infographic: Spondyloarthritis
Overview of spondyloarthritis patient profiles and treatment pathways. Spondyloarthritis is the name for a family of arthritis causing inflammatory rheumatic diseases; including axial spondyloarthritis, psoriatic arthritis and akylosing spondylitis,
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Subscribe to our email news alerts
Featured jobs
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- Sanofi/Regeneron’s Dupixent approved by EC for eosinophilic oesophagitis
- ASH 2022: bad blood but big advances
- Eli Lilly announces $450m investment in US manufacturing site
- Sanofi/Regeneron’s Dupixent recommended by CHMP for atopic dermatitis in children
- Sandoz’s high concentration Hyrimoz formulation recommended for use in EU
- AstraZeneca’s Imfinzi plus chemotherapy approved by MHRA for biliary tract cancer
- ICR calls for improved biomarker cancer tests to help personalise treatment
- EIT Health marks World Cancer Day with €6m pledge for new healthcare delivery models
- World Cancer Day: encouraging men to put their health first
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Strategic behaviour
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- GSK to submit drug application for new antibiotic to US FDA
- EU outlines measures to mitigate antibiotic shortage across Europe
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Neurodiversity and healthcare communications – do we know enough and do we do enough?
PMHub
Four Health
Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...
Latest intelligence
- World Cancer Day 2023 – closing the gaps in cancer care to give more patients access to life-changing medicines
- Great Expectations – exploring the counterpoint between advances in oncology and the challenges of ensuring life-changing medicines reach patients...
- Strategic behaviour
- Strong strategising depends on your colleagues’ behaviour...
- Pharmaceutical Marketing Strategies For The Digital Age
- In the digital age, a strong digital marketing strategy is crucial for businesses, especially in the highly competitive and complex pharmaceutical industry. There are key trends shaping pharmaceutical marketing, such...
